Find A Clinical Trial

Disease Type: Brain

Trial ID BDTX-4933
Sponsor ID BDTX-4933-101

A Phase 1, Open-label Study of BDTX-4933 in Patients With BRAF and Other Select RAS/MAPK Mutation-Positive Neoplasms

Trial ID BDTX-1535
Sponsor ID Black Diamond Therapeutics

A Phase 1 Study to Assess BDTX-1535, an Oral EGFR Inhibitor, in Patients with Glioblastoma or Non-Small Cell Lung Cancer

1 Location